{"id":"arbekacin-sulfate","safety":{"commonSideEffects":[{"rate":"null","effect":"Nephrotoxicity"},{"rate":"null","effect":"Ototoxicity"}]},"_chembl":{"chemblId":"CHEMBL426926","moleculeType":"Small molecule","molecularWeight":"552.63"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Arbekacin sulfate exerts its antibacterial effects by interfering with the initiation complex of peptide formation at the ribosomal subunit, thereby inhibiting protein synthesis in bacteria.","oneSentence":"Aminoglycoside antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:28:58.918Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pneumonia"},{"name":"Skin and soft tissue infections"}]},"trialDetails":[{"nctId":"NCT01659515","phase":"","title":"Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria","status":"NO_LONGER_AVAILABLE","sponsor":"U.S. Army Medical Research and Development Command","startDate":"","conditions":"Infection Due to Resistant Organism","enrollment":""},{"nctId":"NCT01918384","phase":"PHASE2","title":"Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy","status":"UNKNOWN","sponsor":"Kobe University","startDate":"2013-08","conditions":"Muscular Dystrophy, Duchenne","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":26,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Arbekacin","Habekacin"],"phase":"phase_2","status":"active","brandName":"Arbekacin Sulfate","genericName":"Arbekacin Sulfate","companyName":"U.S. Army Medical Research and Development Command","companyId":"u-s-army-medical-research-and-development-command","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aminoglycoside antibiotic that inhibits protein synthesis by binding to the 30S ribosomal subunit. Used for Pneumonia, Skin and soft tissue infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}